Currently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
SPONSORED BY IONIS PHARMACEUTICALS
Advertisement
Articles by SPONSORED BY IONIS PHARMACEUTICALS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Increasing the knowledge base of GA is key to individualizing patient therapy
2
REGENXBIO completes enrollment in ATMOSPHERE and ASCENT trials of sura-vec in wet AMD
3
Academy technician training platform expands education opportunities in ophthalmology
4
Quantifying intermittent retinal capillary perfusion in RVO and PDR
5
.png "Optometry Times"){kind=logo}
